Story

Steris to Invest $600 Million in North Carolina Manufacturing and R&D Hub

ENTHMSVIIDZHZH-TWJAKOHI
Aug 5, 20261 min read
Steris to Invest $600 Million in North Carolina Manufacturing and R&D Hub
Text size
Background

Medical equipment manufacturer Steris (NYSE: STE) announced on Wednesday a $600 million investment to construct a new manufacturing and distribution campus in North Carolina. The facility will be dedicated to producing chemicals for healthcare and pharmaceutical applications.

Project Scope and Consolidation

The planned 600,000-square-foot facility will be located near the Raleigh-Durham Research Triangle region, a prominent hub for technology and life sciences. Steris intends to produce chemicals used for infection prevention and contamination control at the new site.

This investment represents a strategic consolidation for the company. Steris will relocate its existing chemical operations from St. Louis, Missouri, and Plymouth, Minnesota, to the new North Carolina campus once construction is complete. The company projects the site will begin operations within two to three years, with distribution activities commencing before manufacturing begins.

Sample IUX Markets – In-articleAd

Economic Impact and Rationale

The new campus is expected to create approximately 335 jobs spanning manufacturing, research and development (R&D), and distribution roles. According to the announcement, Steris selected North Carolina after a multi-location review, citing the region's access to a deep pool of technical talent and specialized skills as a key factor.

The project is receiving support from state and local economic development programs in North Carolina, as well as from Lee County and the city of Sanford. For investors, this move signals a long-term commitment to streamlining production and leveraging a high-skilled labor market to support future growth in its healthcare and pharma segments.

Read next

More on Stocks
Back to latest news

LATEST